|
IL126999A
(en)
|
1996-07-24 |
2002-03-10 |
Warner Lambert Co |
Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
|
|
ATE323067T1
(de)
|
1997-10-27 |
2006-04-15 |
Warner Lambert Co |
Zyklische aminosäuren und deren derivate als arzneimittel
|
|
US6984659B2
(en)
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
DE19751062A1
(de)
*
|
1997-11-18 |
1999-07-08 |
Univ Ludwigs Albert |
An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels
|
|
CN1131855C
(zh)
*
|
1997-12-16 |
2003-12-24 |
沃尼尔·朗伯公司 |
1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途
|
|
EP1094817A1
(en)
*
|
1998-07-09 |
2001-05-02 |
Warner-Lambert Company |
Compositions comprising gaba analogs and caffeine
|
|
EP1031350A1
(en)
*
|
1999-02-23 |
2000-08-30 |
Warner-Lambert Company |
Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
|
|
US6992109B1
(en)
*
|
1999-04-08 |
2006-01-31 |
Segal Catherine A |
Method for the treatment of incontinence
|
|
WO2001042191A1
(en)
*
|
1999-12-08 |
2001-06-14 |
Warner-Lambert Company |
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
|
|
WO2001072311A1
(en)
*
|
2000-03-28 |
2001-10-04 |
Delorenzo Robert J |
Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
|
|
GB2362646A
(en)
*
|
2000-05-26 |
2001-11-28 |
Warner Lambert Co |
Cyclic amino acid derivatives useful as pharmaceutical agents
|
|
DE10048715A1
(de)
*
|
2000-09-30 |
2004-05-19 |
Grünenthal GmbH |
Verwendung von Aminosäure zur Behandlung von Schmerz
|
|
WO2002028881A1
(en)
*
|
2000-10-06 |
2002-04-11 |
Xenoport, Inc. |
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
|
|
EP1361847A2
(en)
|
2000-10-06 |
2003-11-19 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
|
US6683112B2
(en)
*
|
2000-10-24 |
2004-01-27 |
Andrx Corporation |
Gabapentin prodrugs and formulations
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
DE01981893T1
(de)
*
|
2000-11-02 |
2004-05-19 |
Teva Pharmaceutical Industries Ltd. |
Verbessertes verfahren zur herstellung eines gabapentin-zwischenprodukts
|
|
US20040063994A1
(en)
*
|
2001-03-16 |
2004-04-01 |
Paolo Rossi |
Process for the preparation of cyclic amino acids
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7420002B2
(en)
*
|
2001-06-11 |
2008-09-02 |
Xenoport |
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
|
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US6818787B2
(en)
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7232924B2
(en)
*
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
ATE540678T1
(de)
|
2001-06-11 |
2012-01-15 |
Xenoport Inc |
Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
|
|
EP1471909A4
(en)
*
|
2002-01-16 |
2007-07-25 |
Endo Pharmaceuticals Inc |
PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
|
|
WO2003077902A1
(en)
|
2002-02-19 |
2003-09-25 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
AU2003222033A1
(en)
*
|
2002-03-20 |
2003-10-08 |
Xenoport |
Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
|
|
WO2003094842A2
(en)
*
|
2002-05-07 |
2003-11-20 |
A & D Bioscience, Inc. |
Conjugates comprising central nervous system active drug
|
|
WO2003099338A2
(en)
*
|
2002-05-17 |
2003-12-04 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
WO2004052360A1
(en)
*
|
2002-12-11 |
2004-06-24 |
Xenoport, Inc. |
Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
|
|
WO2004053192A1
(en)
*
|
2002-12-11 |
2004-06-24 |
Xenoport, Inc. |
Orally administered dosage forms of fused gaba analog prodrugs having reduced toxicity
|
|
WO2004054560A1
(en)
|
2002-12-13 |
2004-07-01 |
Warner-Lambert Company Llc |
Alpha-2-delta ligand to treat lower urinary tract symptoms
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
GB0301143D0
(en)
*
|
2003-01-17 |
2003-02-19 |
Amedis Pharm Ltd |
Compounds and their use
|
|
JP2006522146A
(ja)
*
|
2003-03-31 |
2006-09-28 |
ゼノポート，インコーポレイティド |
Ｇａｂａ類似体のプロドラッグを使用するのぼせの治療または予防
|
|
KR20060119971A
(ko)
|
2003-09-11 |
2006-11-24 |
제노포트 인코포레이티드 |
Ｇａｂａ 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방
|
|
NZ545494A
(en)
|
2003-09-12 |
2009-10-30 |
Pfizer |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
|
|
AU2004274002B2
(en)
*
|
2003-09-17 |
2011-04-28 |
Arbor Pharmaceuticals, Llc |
Treating or preventing restless legs syndrome using prodrugs of GABA analogs
|
|
PT1677767E
(pt)
|
2003-10-14 |
2011-10-13 |
Xenoport Inc |
Forma cristalina de análogo de ácido gama-aminobutírico
|
|
US20050176680A1
(en)
|
2003-12-11 |
2005-08-11 |
Sepracor, Inc. |
Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
|
US20050209332A1
(en)
*
|
2004-03-17 |
2005-09-22 |
Hikal Limited |
Gabapentin analogues and process thereof
|
|
US7632864B2
(en)
*
|
2004-03-17 |
2009-12-15 |
Hikal Ltd. |
Gabapentin analogues and process thereof
|
|
CA2570255A1
(en)
|
2004-03-17 |
2005-09-22 |
Hikal Limited |
4-t-butylgabapentin and its synthesis
|
|
CA2584338C
(en)
|
2004-11-04 |
2013-08-06 |
Xenoport, Inc. |
Gabapentin prodrug sustained release oral dosage forms
|
|
WO2008073257A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Xenoport, Inc. |
Use of prodrugs of gaba analogs for treating diseases
|
|
CA2673545A1
(en)
|
2006-12-22 |
2008-07-03 |
Recordati Ireland Limited |
Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids
|
|
WO2008103319A2
(en)
|
2007-02-16 |
2008-08-28 |
Ark Diagnostics, Inc. |
Compounds and methods for use in detecting gabapentin
|
|
WO2008157408A2
(en)
*
|
2007-06-15 |
2008-12-24 |
Xenoport, Inc. |
Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity
|
|
US20090118365A1
(en)
*
|
2007-11-06 |
2009-05-07 |
Xenoport, Inc |
Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain
|
|
CA2706575C
(en)
|
2008-01-25 |
2015-07-14 |
Xenoport, Inc. |
Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
|
|
EP2250148B1
(en)
|
2008-01-25 |
2016-08-17 |
XenoPort, Inc. |
Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
|
|
US7868043B2
(en)
|
2008-01-25 |
2011-01-11 |
Xenoport, Inc. |
Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
|
CN105330603A
(zh)
|
2008-10-08 |
2016-02-17 |
凯飞药业公司 |
Gaba偶联物及其使用方法
|
|
EP2349335B1
(en)
|
2008-10-24 |
2013-08-07 |
ARK Diagnostics, Inc. |
Levetiracetam immunoassays
|
|
US9192681B2
(en)
|
2009-02-24 |
2015-11-24 |
Nektar Therapeutics |
Oligomer-amino acid conjugates
|
|
US20110130454A1
(en)
*
|
2009-11-24 |
2011-06-02 |
Xenoport, Inc. |
Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
US20110124705A1
(en)
*
|
2009-11-24 |
2011-05-26 |
Xenoport, Inc. |
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
EP2945942B1
(en)
|
2013-01-18 |
2018-05-09 |
ARK Diagnostics, Inc. |
Voriconazole immunoassays
|
|
CA2903000C
(en)
|
2013-01-28 |
2021-10-12 |
Hector L. Lopez |
Methods of improving tolerability, pharmacodynamics, and efficacy of .beta.-alanine and use therefor
|
|
US9920136B2
(en)
|
2013-02-13 |
2018-03-20 |
Ark Diagnostics, Inc. |
Posaconazole immunoassays
|
|
CN112424158A
(zh)
|
2018-05-14 |
2021-02-26 |
昌郁医药公司 |
萘普生和普瑞巴林的1-(酰氧基)-烷基氨基甲酸酯药物缀合物的结晶形式
|